Hims & Hers shares slide as costly weight-loss push squeezes margins
Hims & Hers shares declined as analysts warned that aggressive spending on weight-loss drugs is compressing profit margins, prompting a trimmed earnings outlook despite raised revenue forecasts.
reuters · 2026-08-11 04:21 UTC